General FAQs

When was AstraZeneca PLC formed?

AstraZeneca was formed on 6 April 1999 through the merger of Astra AB of Sweden and Zeneca PLC of UK.

Where can I find historical financial information on AstraZeneca?

This information can be found in the financial reports section at AstraZeneca.com 

How much does AstraZeneca invest in research and development (R&D)?

We spend around $14million each working day on R&D. In 2005 our total R&D spend was $3.5 billion, which represented 18.3% of sales.

How many people does AstraZeneca employ worldwide?

We have over 65,000 employees worldwide:
18% in the United Kingdom
21% in Sweden
21% in  the U.S
40% in the rest of the world

When is the AstraZeneca annual meeting?

The next Annual General Meeting will be held in April 2007 in London with a satellite link to Sweden. Timings are to be confirmed click here . 

When is AstraZeneca’s next earnings release?

We will announce fourth quarter and full year results 2006 on 1 February 2007. Timings are to be confirmed click here .

What is AstraZeneca's current debt rating?

A-1+ (Standard & Poors) and F 1+ (Fitch) for Short Term ratings, and AA+ (S & P) and AA+ (Fitch) for Long Term ratings.

On what stock exchanges is AstraZeneca traded and what is the stock symbol?

AstraZeneca is traded on the London, New York and Stockholm Stock Exchanges. The symbol is AZN in all three markets.

What is AstraZeneca's CUSIP number for its ADRs/ADSs traded on the New York Stock Exchange?

046353108

How many shares does AstraZeneca have outstanding?

As at 30 September 2006 there were 1,551 million shares in issue.

What accounting convention does AstraZeneca adhere to?

AstraZeneca adheres to UK GAAP (Generally Accepted Accounting Principles) with appropriate conversion to US GAAP being shown in our financial statements.What is AstraZeneca's official accounting currency?AstraZeneca reports in US dollars.